June 2014 FDA Recall Famotidine by Novel Laboratories, Inc.
D-1484-2014 - Failed Impurity/Degradation Specification; 12-month stability time point

This Class III drug recall was voluntarily initiated by Novel Laboratories, Inc. on June 20, 2014 for the product Famotidine. The FDA reported the reason for recall as failed impurity/degradation specification; 12-month stability time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1484-2014

Reason for Recall
Failed Impurity/Degradation Specification; 12-month stability time point
Initiated
06-20-2014
Reported
09-03-2014
Quantity
25,776 containers

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Novel Laboratories, Inc.
Famotidine for Oral Suspension, USP 40 mg/5 mL, Rx Only, Cherry-Banana-Mint Flavored, Not for Injection, Manufactured by: Novel Laboratories, Inc., Somerset, NJ 08873. Distributed by: Gavis Pharmaceuticals, LLC, Somerset, NJ 08873, NDC 43386-500-11.

Batch or Lot Expiration Information

Lot# 's M13075A, M13076A, M13076B, M13077A, M13077B all with expiry dated 2/2015 and M13490A with expiry date 3/2016.

Affected Packages Involved in this Recall